These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24756021)
21. Ornithine phenylacetate revisited. Jover-Cobos M; Noiret L; Sharifi Y; Jalan R Metab Brain Dis; 2013 Jun; 28(2):327-31. PubMed ID: 23456516 [TBL] [Abstract][Full Text] [Related]
22. Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs. Ahn JO; Li Q; Lee YH; Han SM; Hwang CY; Youn HY; Chung JY J Vet Sci; 2016 Sep; 17(3):431-3. PubMed ID: 26726023 [TBL] [Abstract][Full Text] [Related]
23. Acetyl-L-carnitine in hepatic encephalopathy. Malaguarnera M Metab Brain Dis; 2013 Jun; 28(2):193-9. PubMed ID: 23389620 [TBL] [Abstract][Full Text] [Related]
24. [Prevention and treatment of hepatic encephalopathy]. Sivolap YP Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503 [TBL] [Abstract][Full Text] [Related]
25. L-Ornithine L-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic. Butterworth RF Drugs; 2019 Feb; 79(Suppl 1):1-3. PubMed ID: 30706421 [No Abstract] [Full Text] [Related]
26. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. Fiati Kenston SS; Song X; Li Z; Zhao J J Gastroenterol Hepatol; 2019 Jan; 34(1):31-39. PubMed ID: 30070387 [TBL] [Abstract][Full Text] [Related]
27. Neurotoxicity of Ammonia. Oja SS; Saransaari P; Korpi ER Neurochem Res; 2017 Mar; 42(3):713-720. PubMed ID: 27465396 [TBL] [Abstract][Full Text] [Related]
28. Cellular Pathogenesis of Hepatic Encephalopathy: An Update. Lu K Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830765 [TBL] [Abstract][Full Text] [Related]
29. Impact of intestinal mannitol on hyperammonemia, oxidative stress and severity of hepatic encephalopathy in the ED. Montes-Cortés DH; Novelo-Del Valle JL; Olivares-Corichi IM; Rosas-Barrientos JV; Jara LJ; Cruz-Domínguez MP Am J Emerg Med; 2018 Sep; 36(9):1570-1576. PubMed ID: 29352675 [TBL] [Abstract][Full Text] [Related]
30. Brain metabolism in hepatic encephalopathy and hyperammonemia. Hawkins RA; Mans AM Adv Exp Med Biol; 1993; 341():13-9. PubMed ID: 8116483 [No Abstract] [Full Text] [Related]
31. Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy. Agusti A; Llansola M; Hernández-Rabaza V; Cabrera-Pastor A; Montoliu C; Felipo V J Steroid Biochem Mol Biol; 2016 Jun; 160():88-93. PubMed ID: 26307490 [TBL] [Abstract][Full Text] [Related]
33. Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy. Atiq M; Holt AF; Safdar K; Weber F; Ravinuthala R; Jonas ME; Neff GW J Clin Gastroenterol; 2008 Feb; 42(2):213-4. PubMed ID: 18209596 [TBL] [Abstract][Full Text] [Related]
34. Identifying the direct effects of ammonia on the brain. Bosoi CR; Rose CF Metab Brain Dis; 2009 Mar; 24(1):95-102. PubMed ID: 19104924 [TBL] [Abstract][Full Text] [Related]
36. NMDA receptors in hyperammonemia and hepatic encephalopathy. Llansola M; Rodrigo R; Monfort P; Montoliu C; Kosenko E; Cauli O; Piedrafita B; El Mlili N; Felipo V Metab Brain Dis; 2007 Dec; 22(3-4):321-35. PubMed ID: 17701332 [TBL] [Abstract][Full Text] [Related]
37. Ammonia-mediated LTP inhibition: effects of NMDA receptor antagonists and L-carnitine. Izumi Y; Izumi M; Matsukawa M; Funatsu M; Zorumski CF Neurobiol Dis; 2005 Nov; 20(2):615-24. PubMed ID: 15935684 [TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori eradication for hepatic encephalopathy treatment: the ideal study is still lacking! Zullo A; Ridola L; De Francesco V; Hassan C J Clin Gastroenterol; 2015 Jan; 49(1):88-9. PubMed ID: 25485514 [No Abstract] [Full Text] [Related]